PennyOmega.com Hot Stock News & Alerts!

________________________________________

FREE Daily Stock Alerts From PennyOmega.com

________________________________________

PennyOmega.com Watch List!

Our Picks at PennyOmega.com for Monday Feb. 01, 2010 are:

**************************************************************

BGOI, Bonanza Oil & Gas, Inc., BGOI.OB

BGOI, an independent oil and gas company, is a Nevada Corporation based in Texas.

BGOI’s business plan incorporates several models that capture and exploit PUDs (Proven Undeveloped reserves).

** BGOI reported that the production level of the Jackson Well in the Apclark Field, operated by Westerly Exploration, Inc., appears to be increasing, after the re-fracturing stimulation of that well. Apclark Field is 5 miles East of the Jo Mill Field that has produced over 54,000,000 barrels of oil.

You should consider this, because BGOI’s original working interest for Apclark is a PV-10 value, per third party engineering, of $17mm.

And it looks like investors have noticed that BGOI is doing well. Just take a look at BGOI’s 5 days chart:

Keep a close eye on BGOI from now, because as you can see, BGOI’s trading levels are changing really fast and you don’t want to be out of the action!!!

More about BGOI at www.bonanzaog.com

**************************************************************

PWRM, Power 3 Medical Products Inc, PWRM.OB

PWRM is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.

PWRM’s patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets, and its diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC- SeraPro).

PWRM continues to evolve and enhance its IP portfolio, employing sensitive and specific combinations of biomarkers it has discovered from a broad range of diseases as the basis of highly selective blood-based tests for ALS, Alzheimer’s, and Parkinson’s diseases, breast cancer, and drug resistance.

** Tomorrow: PWRM will be a sponsor and have an exhibit booth at the 4th Annual Conference of the Alzheimer’s Drug Discovery Foundation on Drug Discovery for Neurodegeneration in Houston on February 1-2, 2010.

You should consider this, because PWRM’s products gonna get a HUGE exposure on that event. Furthermore:

- There are no other current blood based test available for early stage diagnosis or monitoring of therapies in development.

- U.S. alone presents PWRM a screening opportunity worth $31.2 billion (Source: NIMH, Alzheimer’s Association)

- PWRM expects to complete phase II clinical validation trials of its blood serum diagnostics for Alzheimer’s disease (NuroPro-AD), Parkinson’s disease (NuroPro-PD) and breast cancer in 2010, followed by filings with the FDA.

Put PWRM on your radar, because after that event, its trading levels could change in no time and the rally could be coming!!

More about PWRM at www.Power3Medical.com

**************************************************************

BGOI and PWRM are on PennyOmega.com’s RADAR! Do your Homework, and like always BE READY for the Action!!!

**************************************************************

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) . Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and it has received an additional 1,000,000 shares 144 restricted stocks for 6 months of advertisement and diseminate news and $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB).